. Author manuscript; available in PMC: 2021 Jun 17.

Published in final edited form as: Lancet Haematol. 2017 Mar 20;4(5):e225–e236. doi: 10.1016/S2352-3026(17)30027-3

Table 3:

Patients in the intention-to-treat population overall and prespecified platelet subgroups achieving ≥50% reduction in Total Symptom Score 2.0 at weeks 24 and 48

	Week 24			Week 48
	Pacritinib	BAT	p value	Pacritinib	BAT	p value
Overall	19/100 (19%)	5/48 (10%)	0∙24	15/100 (15%)	0/48	0∙0027
Platelets
<100 000/μL	7/28 (25%)	1/13 (8%)	0∙40	3/28 (11%)	0/13	0∙54
<50 000/μL	3/11 (27%)	0/5	0∙51	2/11 (18%)	0/5	1∙0

Data are n/N (%).